A single nasal allergen challenge increases induced sputum inflammatory markers in non‐asthmatic subjects with seasonal allergic rhinitis: correlation with plasma interleukin‐5

Background Seasonal allergic rhinitis (SAR) is a risk factor for asthma in affected individuals. Nasal allergic inflammation enhances bone‐marrow eosinophil production, mainly via IL‐5, and rhinitis patients have increased airway inflammation during the pollen season.

[1]  J. Byström,et al.  Eosinophil cationic protein is stored in, but not produced by, peripheral blood neutrophils , 2002, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[2]  M. Kelly,et al.  Increased detection of interleukin-5 in sputum by addition of protease inhibitors. , 2001, The European respiratory journal.

[3]  R. Buhl,et al.  Induced sputum cell profiles in lung transplant recipients with or without chronic rejection: correlation with lung function , 2001, Thorax.

[4]  J. Kantelip,et al.  Inhibition of IgE‐induced activation of human mast cells by IL‐10 , 2001, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[5]  H. Hoogsteden,et al.  Nasal allergen provocation induces adhesion molecule expression and tissue eosinophilia in upper and lower airways. , 2001, The Journal of allergy and clinical immunology.

[6]  Lin Ying Liu,et al.  The relationship of sputum eosinophilia and sputum cell generation of IL-5. , 2000, The Journal of allergy and clinical immunology.

[7]  A. Togias.  Systemic immunologic and inflammatory aspects of allergic rhinitis. , 2000, The Journal of allergy and clinical immunology.

[8]  M. Kelly,et al.  Induced sputum: validity of fluid-phase IL-5 measurement. , 2000, The Journal of allergy and clinical immunology.

[9]  J. Hankinson,et al.  Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. , 2000, American journal of respiratory and critical care medicine.

[10]  H. Hoogsteden,et al.  Segmental bronchial provocation induces nasal inflammation in allergic rhinitis patients. , 2000, American journal of respiratory and critical care medicine.

[11]  M. Pretolani.  Interleukin‐10: an anti‐inflammatory cytokine with therapeutic potential , 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[12]  Venge,et al.  Eosinophil cationic protein (ECP): molecular and biological properties and the use of ECP as a marker of eosinophil activation in disease , 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[13]  P. O'Byrne,et al.  Kinetics of allergen-induced airway eosinophilic cytokine production and airway inflammation. , 1999, American journal of respiratory and critical care medicine.

[14]  K. H. Leung.  Release of soluble ICAM-1 from human lung fibroblasts, aortic smooth muscle cells, dermal microvascular endothelial cells, bronchial epithelial cells, and keratinocytes. , 1999, Biochemical and biophysical research communications.

[15]  P. O'Byrne,et al.  Interleukin-5 and allergic inflammation. , 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[16]  S. Qin,et al.  Inhaled IL-5 increases concentrations of soluble intracellular adhesion molecule-1 in sputum from atopic asthmatic subjects. , 1999, The Journal of allergy and clinical immunology.

[17]  T. Holmen,et al.  Exhaled and nasal NO levels in allergic rhinitis: relation to sensitization, pollen season and bronchial hyperresponsiveness. , 1999, The European respiratory journal.

[18]  P. Wollmer,et al.  Demonstration of bronchial eosinophil activity in seasonal allergic rhinitis by induced plasma exudation combined with induced sputum , 1999, Thorax.

[19]  M. Klinnert,et al.  Interleukin-10 and transforming growth factor-β promoter polymorphisms in allergies and asthma , 1998 .

[20]  P. O'Byrne,et al.  Changes in bone marrow inflammatory cell progenitors after inhaled allergen in asthmatic subjects. , 1998, American journal of respiratory and critical care medicine.

[21]  S. Bonini,et al.  Provocation tests with allergens , 1997 .

[22]  J. Corren.  Allergic rhinitis and asthma: how important is the link? , 1997, The Journal of allergy and clinical immunology.

[23]  A. Foresi,et al.  Once daily intranasal fluticasone propionate (200 micrograms) reduces nasal symptoms and inflammation but also attenuates the increase in bronchial responsiveness during the pollen season in allergic rhinitis. , 1996, The Journal of allergy and clinical immunology.

[24]  F. Hargreave,et al.  Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. , 1996, American journal of respiratory and critical care medicine.

[25]  S. Wenzel,et al.  Interleukin-10 regulation in normal subjects and patients with asthma. , 1996, The Journal of allergy and clinical immunology.

[26]  B. Niggemann,et al.  Individual time‐courses of ECP and EPX during allergen provocation tests in asthmatic children , 1995, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[27]  E. Knol,et al.  Eosinophils isolated with two different methods show different characteristics of activation. , 1995, Journal of immunological methods.

[28]  R. Schleimer,et al.  The role of adhesion molecules in human eosinophil and basophil recruitment. , 1994, The Journal of allergy and clinical immunology.

[29]  D. Proud,et al.  Soluble intracellular adhesion molecule 1 in bronchoalveolar lavage fluid of allergic subjects following segmental antigen challenge. , 1994, American journal of respiratory and critical care medicine.

[30]  L. Lichtenstein,et al.  Blood and bronchoalveolar eosinophils in allergic subjects after segmental antigen challenge: surface phenotype, density heterogeneity, and prostanoid production. , 1994, The Journal of allergy and clinical immunology.

[31]  S. Durham,et al.  Expression of endothelial and leukocyte adhesion molecules interacellular adhesion molecule-1, E-selectin, and vascular cell adhesion molecule-1 in the bronchial mucosa in steady-state and allergen-induced asthma. , 1993, The Journal of allergy and clinical immunology.

[32]  F. Neukirch,et al.  Different effects of nasal and bronchial glucocorticosteroid administration on bronchial hyperresponsiveness in patients with allergic rhinitis. , 1992, The American review of respiratory disease.

[33]  C. Irvin,et al.  Changes in bronchial responsiveness following nasal provocation with allergen. , 1992, The Journal of allergy and clinical immunology.

[34]  T. Mosmann,et al.  IL-10 inhibits cytokine production by activated macrophages. , 1991, Journal of immunology.

[35]  J. Bousquet,et al.  Eosinophilic inflammation in asthma. , 1990, The New England journal of medicine.

[36]  P. Bardin,et al.  Absence of pulmonary aspiration of sinus contents in patients with asthma and sinusitis. , 1990, The Journal of allergy and clinical immunology.

[37]  R. Millman,et al.  Changes in airway resistance following nasal provocation. , 1990, The American review of respiratory disease.

[38]  D. Nolte,et al.  On vagal bronchoconstriction in asthmatic patients by nasal irritation. , 1983, European journal of respiratory diseases. Supplement.